Corcept Therapeutics, Inc. (CORT) Posts Narrower than Expected Q2 Loss of 9c/Share
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $122.25 +0.99%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q2 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- RenovoRx regains Nasdaq minimum bid price compliance
- S&P 500 may pull back before midterms, but Citi says buy the dip
Create E-mail Alert Related Categories
Earnings, Trading HaltsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
